Data from all these studies showed that TEVs carrying PD-L1 have a critical role in inhibiting proliferation and activation of CD4+ and CD8+ T cells as well as their infiltration into the tumor microenvironment, drastically affecting the processes of immune surveillance and promoting tumor progression. The gene discussed is CD8A; the disease is neoplasm.